HepaSphere Interventional Therapy Using Digital Subtraction Angiography(DSA) for Liver Cancer

NCT02447263 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
87
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Fuda Cancer Hospital, Guangzhou